Advertisement
Новости Форекс
German Import Prices Fall Most In Nearly 40 Years
Germany's import prices declined at the fastest pace in almost four decades, mainly due to base effect from the surge in prices in the same month last year due to the war in Ukraine, the statistical office Destatis said Friday.
RTTNews |
683 дней спустя
Cathay Group Orders 32 A320neo Family Aircraft From Airbus
Hong Kong's Cathay Group announced Friday the purchase of an additional 32 Airbus A320neo Family aircraft as part of its continued investment in expanding and modernizing its fleet.
RTTNews
|
683 дней спустя
U.S. Personal Income Increases In Line With Estimates In August
Personal income in the U.S. increased in line with economist estimates in the month of August, according to a report released by the Commerce Department on Friday. The report said personal income climbed by 0.4 percent in August after rising by 0.2 percent in July. The advance matched economist estimates.
RTTNews
|
683 дней спустя
Dollar Ticks Up After U.S. Personal Income And Spending Data
U.S. personal income and spending data for August has been released at 8:30 am ET Friday. After the data, the greenback inched up against its major rivals.
RTTNews
|
683 дней спустя
Dollar Mixed Ahead Of U.S. Personal Income And Spending Data
U.S. personal income and spending data for August is due at 8:30 am ET Friday. Ahead of the data, the greenback traded mixed against its major rivals. While it fell against the pound, it held steady against the rest of major rivals.
RTTNews
|
683 дней спустя
Structure Therapeutics Sets $300 Mln Private Placement Equity Financing
Biopharmaceutical company Structure Therapeutics Inc. (GPCR) announced Friday it has entered into a share purchase agreement for the sale of 21.62 million ordinary shares and 2.40 million newly designated non-voting ordinary shares (the equivalent of an aggregate of 8.01 million American Depositary Shares, each representing three ordinary shares) at $12.49 per share (based on the closing price of $37.47 per ADS on September 28, 2023) through a private placement financing.
RTTNews
|
683 дней спустя
Eurozone Inflation Near 2-Year Low
Euro area inflation weakened sharply in September to the lowest level since late 2021 after ten consecutive interest rate hikes from the European Central Bank, but the monetary policy is expected to remain tight for longer as the 2 percent target is still away. Inflation eased sharply to 4.3 percent in September from 5.2 percent in August, flash data from Eurostat revealed Friday.
RTTNews
|
683 дней спустя
more news
UK Mortgage Approvals At 6-Month Low
UK mortgage approvals fell to a six-month low in August as rising interest rates weighed on housing market activity, official data revealed on Friday. Approvals for house purchases fell to 45,400 in August from 49,500 in July, the Bank of England reported. The expected level was 45,000.
RTTNews
|
683 дней спустя
Vestas Secures 38 MW Order With Toda For Iwaki Miwa Wind Farm In Japan
Vestas Wind Systems A/S (VWDRY.PK) announced Friday it has secured a 38 MW order with Toda Corp. for Iwaki Miwa Wind Farm in Fukushima prefecture, Japan.
RTTNews
|
683 дней спустя
Bay Street Likely To Open On Firm Note
Canadian shares are headed for a fairly bright start Friday morning, tracking firm global stocks and higher commodity prices. The focus will be on Canadian GDP, and U.S. personal expenditure data.
RTTNews
|
683 дней спустя
Indian Rupee Rises To 4-day High Against U.S. Dollar
The Indian rupee climbed against the U.S. dollar in evening deals on Friday, as the latter fell ahead of a key inflation report due today.
RTTNews
|
683 дней спустя
UK Economy Logs Stronger Than Estimated Growth
The UK economy registered a stronger than estimated recovery in the first half of the year despite high inflation and tighter monetary policy. Gross domestic product registered a sequential growth of 0.2 percent in the second quarter, which was unchanged from the first estimate, the Office for National Statistics reported Friday.
RTTNews
|
683 дней спустя
AbbVie Says Phase 3 CANOVA Trial Fails To Meet Primary Endpoint
AbbVie (ABBV) announced Friday data from its Phase 3 CANOVA study evaluating the safety and efficacy of venetoclax (VENCLEXTA®/ VENCLYXTO®) plus dexamethasone (VenDex) for patients with t(11;14)-positive relapsed or refractory (R/R) multiple myeloma who have received two or more prior treatments.
RTTNews
|
683 дней спустя
Stay up to date!
Add Новости to your browser
Add To Chrome
